NO179358C - Use of substituted benzofuranyl piperidines as nootropics - Google Patents

Use of substituted benzofuranyl piperidines as nootropics

Info

Publication number
NO179358C
NO179358C NO920591A NO920591A NO179358C NO 179358 C NO179358 C NO 179358C NO 920591 A NO920591 A NO 920591A NO 920591 A NO920591 A NO 920591A NO 179358 C NO179358 C NO 179358C
Authority
NO
Norway
Prior art keywords
nootropics
piperidines
substituted benzofuranyl
treatment
disorders
Prior art date
Application number
NO920591A
Other languages
Norwegian (no)
Other versions
NO179358B (en
NO920591D0 (en
NO920591L (en
Inventor
Cesare Mondadori
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO920591D0 publication Critical patent/NO920591D0/en
Publication of NO920591L publication Critical patent/NO920591L/en
Publication of NO179358B publication Critical patent/NO179358B/en
Publication of NO179358C publication Critical patent/NO179358C/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

4-(7-Bromo-5-methoxybenzofuran-2-yl)piperidine of the formula I <IMAGE> and its pharmaceutically utilisable salts can be used as pharmaceutical active ingredients for slowing down the degeneration of nerve cells associated with degenerative neurological disorders, and as nootropics for the treatment of disorders which respond to nootropic treatment.
NO920591A 1991-02-15 1992-02-14 Use of substituted benzofuranyl piperidines as nootropics NO179358C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH47091 1991-02-15

Publications (4)

Publication Number Publication Date
NO920591D0 NO920591D0 (en) 1992-02-14
NO920591L NO920591L (en) 1992-08-17
NO179358B NO179358B (en) 1996-06-17
NO179358C true NO179358C (en) 1996-09-25

Family

ID=4187740

Family Applications (1)

Application Number Title Priority Date Filing Date
NO920591A NO179358C (en) 1991-02-15 1992-02-14 Use of substituted benzofuranyl piperidines as nootropics

Country Status (16)

Country Link
EP (1) EP0499586B1 (en)
JP (1) JPH0570352A (en)
KR (1) KR920016098A (en)
AT (1) ATE138805T1 (en)
AU (1) AU655227B2 (en)
CA (1) CA2061015A1 (en)
DE (1) DE59206442D1 (en)
DK (1) DK0499586T3 (en)
ES (1) ES2087497T3 (en)
GR (1) GR3020155T3 (en)
IE (1) IE74906B1 (en)
IL (1) IL100889A (en)
MX (1) MX9200620A (en)
NO (1) NO179358C (en)
NZ (1) NZ241608A (en)
ZA (1) ZA921091B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993016696A1 (en) * 1992-02-21 1993-09-02 Ciba-Geigy Ag Brofaromine as an agent for treating social phobia

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989003692A1 (en) * 1987-10-22 1989-05-05 Massachusetts Institute Of Technology Treating premenstrual or late luteal phase syndrome

Also Published As

Publication number Publication date
DE59206442D1 (en) 1996-07-11
IE74906B1 (en) 1997-08-13
DK0499586T3 (en) 1996-06-24
KR920016098A (en) 1992-09-24
ES2087497T3 (en) 1996-07-16
IL100889A0 (en) 1992-11-15
EP0499586B1 (en) 1996-06-05
IL100889A (en) 1997-03-18
NZ241608A (en) 1997-06-24
AU1087792A (en) 1992-08-20
NO179358B (en) 1996-06-17
MX9200620A (en) 1992-08-01
NO920591D0 (en) 1992-02-14
AU655227B2 (en) 1994-12-08
JPH0570352A (en) 1993-03-23
IE920486A1 (en) 1992-08-26
NO920591L (en) 1992-08-17
EP0499586A1 (en) 1992-08-19
GR3020155T3 (en) 1996-09-30
ATE138805T1 (en) 1996-06-15
ZA921091B (en) 1992-09-30
CA2061015A1 (en) 1992-08-16

Similar Documents

Publication Publication Date Title
NO931056D0 (en) SULPHONAMIDO AND SULPHONAMIDOCARBONYL-PYRIDINE-2-CARBOXYLIC ACID AMIDES AND THEIR PYRIDINE-N-OXIDES, PROCEDURES FOR PREPARING THEREOF AND USING THE COMPOUNDS AS MEDICINES
ES2139638T3 (en) 1,4-DISPUTED PIPERAZINES FOR THE TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM AND NEUROENDOCRINE DISEASES.
DK0725779T3 (en) New (R) -5-Carbamoyl-8-fluoro-3-N, N-disubstituted-amino-3,4-dihydro-2H-1-benzopyrans
ES8705387A1 (en) N-Aryl-N-(4-Piperidinyl)amides and pharmaceutical compositions and methods employing such compounds.
FI962324A0 (en) N-substituted azabicycloalkane derivatives as neuroleptic ASF
ES2168260T3 (en) 3-SUBSTITUTED AMINOQUINUCLIDINS.
DK0633259T3 (en) Newly known sulfonylaminopyrimidines, their preparation and their use as drugs
NO921609L (en) SULPHONAMIDS AND THEIR MEDICAL USE
GEP20022636B (en) 4-[5-Methyl-3-Phenylisoxazol-4-Yl] Benzenesulfonamide, Its Crystal Structure B, Pharmaceutical Composition Containing The Same, Methods For Treatment Or Prophylaxis Of Disorders Caused By Cyclooxygen-2
NO953967L (en) Indole derivatives such as 5-HT1A and / or 5-HT2 ligands
DE69216293D1 (en) 1,4-disubstituted piperidine derivatives, their preparation and therapeutic use
NO180632C (en) 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents
ES2179094T3 (en) DERIVATIVES OF CYCLIC AMIDES AS ANTAGONISTS OF NEUROQUININA A.
NO881308L (en) DIHYDROPYRIDINAMIDES, PROCEDURES FOR THEIR PREPARATION AND THEIR USE IN PHARMACEUTICALS.
NO179358C (en) Use of substituted benzofuranyl piperidines as nootropics
NO307029B1 (en) Use of 4-chloro-5 - [(4,5-dihydro-1H-imidazol-2-yl) -amino] -6-methoxy-2-methylpyrimidine in the preparation of pharmaceutical compositions for the treatment of hyperglycemia
NO982863L (en) New compounds with analgesic effect
EP0535250A4 (en) Novel compounds and use thereof as medicine
BR0016516A (en) Replaced pyrroles
NO933521D0 (en) ACYLSULPHONAMIDO AND SULPHONAMIDOPYRIDINE-2-CARBOXYLIC ACID RESIDES, AND THEIR PYRIDINE-N-OXYDES, PROCEDURES FOR THEIR PREPARATION AND THEIR USE AS A MEDICINE
SE8603517D0 (en) HETEROCYCLIC COMPOUNDS AND THEIR PREPARATION AND PHARMACEUTICAL FORMULATION
EP0344982A3 (en) Alpha-adrenergic receptor antagonists
MX9405318A (en) PYRIMIDONES AND IMIDAZOLINONES FOR TREATMENT OF THE SHOCK.
DK0573360T3 (en) Pyrrolothienopyrazine Compounds as 5-HT3 Receptor Antagonists